Pfizer to consider stockpiling medicines in preperation for no-deal Brexit
August 6, 2018Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling
Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …
England’s top GP resigns over imflammatory online comments
August 6, 2018Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma
England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …
Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest
August 6, 2018Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby
The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …
Top Ten most popular articles on Pharmafile.com this week
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10
While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
Almirall picks up Allergan’s dermatology portfolio to for $650m
August 3, 2018Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma
Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …
Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold
August 3, 2018Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat
Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …
Allergan sues Pfizer over opioid crisis lawsuits
August 3, 2018Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …
Computer simulations predict spread of HIV
August 3, 2018Medical Communications
Researchers at the Los Alamos National Laboratory have developed a computer simulation that is able to accurately predict the transmission …
Lawsuit alleges pharma giants funded terror in Iraq
August 2, 2018Business Services, Medical Communications, Sales and Marketing AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism
The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that …
Novartis hands over global rights for two oncology drugs to Shanghai’s Laekna
August 2, 2018Sales and Marketing Cancer, Laekna, Novartis, oncology, pharma
Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …
Two injured in chemical incident at Sanofi lab in Ireland
August 2, 2018Manufacturing and Production Ireland, Sanofi, pharma
Two female employees have been injured in a chemical incident at a Sanofi lab at the company’s Waterford site in …
EMA to cut activities as it forecasts loss of 30% of staff
August 2, 2018Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff
The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …
Biosimilars and generics saved NHS £324m last year
August 2, 2018Medical Communications, Sales and Marketing Cancer, NHS, biosimilars, funding, generics
The NHS watchdog, NHS Improvement, has revealed that the British National Health Service saved £324 million last financial year by …
Sanofi join AstraZeneca and MSD in stockpiling medicines, 1800 jobs at risk
August 1, 2018Research and Development Jobs, Sanofi, brexit, manufacturing, stockpiling
French multinational Sanofi have begun stockpiling drugs in preparation for a no-deal Brexit. The company will join AstraZeneca and MSD …
Otsuka scores EU schizophrenia approval, but acute myeloid leukaemia drug flops at Phase 3
August 1, 2018Research and Development, Sales and Marketing Astex, Otsuka, Rxulti, guadecitabine, pharma, schizophrenia
It’s bittersweet news for Otsuka as it emerges that the European Commission saw fit to approve its therapy Rxulti (brexpiprazole) …
Parents demonstrate in response to Chinese vaccine scandal
August 1, 2018Concerned parents have begun demonstrating in Beijing in response to the Changsheng Biotechnology vaccine scandal. More than two dozen protestors …
Pfizer notches two EU approvals, including Herceptin biosimilar
August 1, 2018Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma
Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …
Pharma CEO Ian Read forcasts rebate-free drug market
August 1, 2018Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates
The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …
FDA rejects Insys Therapeutics sublingual opioid spray
July 31, 2018Manufacturing and Production Crisis, FDA, insys, opioid, rejection, spray
The FDA has rejected Insys Therapeutics buprenorphine sublingual spray due to concerns about the safety of the Arizona-based company’s opioid …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
